Javascript must be enabled to continue!
Mucorales fungi suppress nitric oxide production by macrophages
View through CrossRef
ABSTRACT
Mucormycosis is classified by the National Institute of Allergy and Infectious Diseases as an emerging disease and is caused by
Mucorales
fungi. Despite the high morbidity and mortality rates associated with the disease, little is known about the host-pathogen interactions that dictate disease progression. The recent surge of mucormycosis cases among COVID-19 patients has thrust the disease and the lack of available treatments into the spotlight. Despite severe fungal angioinvasion and tissue necrosis during infection, clinical observations suggest a lack of pro-inflammatory responses. Understanding immune evasion mechanisms in mucormycosis can help guide potential therapeutic options. In this study, we demonstrate that
Mucorales
fungi can suppress the accumulation of nitric oxide (NO) in lipopolysaccharide- and interferon gamma-stimulated macrophages despite robust expression of the
Nos2
mRNA and inducible nitric oxide synthase protein. This suppressive activity requires fungal viability and direct contact with macrophages and is not due to restricted access to L-arginine substrate. While
Mucorales
fungi appear to be able to remove NO from its environment, it does not account for the full suppression that we observe and suggests that
Mucorales
employs at least two mechanisms. Future experiments will elucidate the mechanisms by which
Mucorales
fungi deplete NO accumulation by macrophages and the implications of this depletion in mucormycosis pathogenesis.
IMPORTANCE
In October 2022,
Mucorales
fungi were listed in the “High Priority Group” on the first-ever list of fungal priority pathogens by the World Health Organization. As the causative agent of mucormycosis,
Mucorales
have become of great clinical and public health importance with growing mucormycosis numbers, notably with the exponential rise of COVID-19-associated mucormycosis cases. Despite the dire need, there are limited therapeutic options to treat mucormycosis. Our research fills in critical gaps of knowledge about how
Mucorales
fungi evade the host immune system. Specifically, we offer evidence that
Mucorales
block nitric oxide production, which is a key mediator and signaling molecule of the mammalian innate immune response to microbial pathogens. Our work offers new insight into immune evasion mechanisms by
Mucorales
fungi.
Title: Mucorales
fungi suppress nitric oxide production by macrophages
Description:
ABSTRACT
Mucormycosis is classified by the National Institute of Allergy and Infectious Diseases as an emerging disease and is caused by
Mucorales
fungi.
Despite the high morbidity and mortality rates associated with the disease, little is known about the host-pathogen interactions that dictate disease progression.
The recent surge of mucormycosis cases among COVID-19 patients has thrust the disease and the lack of available treatments into the spotlight.
Despite severe fungal angioinvasion and tissue necrosis during infection, clinical observations suggest a lack of pro-inflammatory responses.
Understanding immune evasion mechanisms in mucormycosis can help guide potential therapeutic options.
In this study, we demonstrate that
Mucorales
fungi can suppress the accumulation of nitric oxide (NO) in lipopolysaccharide- and interferon gamma-stimulated macrophages despite robust expression of the
Nos2
mRNA and inducible nitric oxide synthase protein.
This suppressive activity requires fungal viability and direct contact with macrophages and is not due to restricted access to L-arginine substrate.
While
Mucorales
fungi appear to be able to remove NO from its environment, it does not account for the full suppression that we observe and suggests that
Mucorales
employs at least two mechanisms.
Future experiments will elucidate the mechanisms by which
Mucorales
fungi deplete NO accumulation by macrophages and the implications of this depletion in mucormycosis pathogenesis.
IMPORTANCE
In October 2022,
Mucorales
fungi were listed in the “High Priority Group” on the first-ever list of fungal priority pathogens by the World Health Organization.
As the causative agent of mucormycosis,
Mucorales
have become of great clinical and public health importance with growing mucormycosis numbers, notably with the exponential rise of COVID-19-associated mucormycosis cases.
Despite the dire need, there are limited therapeutic options to treat mucormycosis.
Our research fills in critical gaps of knowledge about how
Mucorales
fungi evade the host immune system.
Specifically, we offer evidence that
Mucorales
block nitric oxide production, which is a key mediator and signaling molecule of the mammalian innate immune response to microbial pathogens.
Our work offers new insight into immune evasion mechanisms by
Mucorales
fungi.
Related Results
Induction of hepatic ito cell nitric oxide production after acute endotoxemia
Induction of hepatic ito cell nitric oxide production after acute endotoxemia
Nitric oxide is a highly reactive mediator released in the liver by hepatocytes, Kupffer cells and endothelial cells during endotoxin-induced inflammation. In this study we determi...
Impact de l'IL-13 dans l'acquisition des fonctions tumoricides des macrophages : rôle des récepteurs lectine de type-C et implication dans la progression d'un lymphome T
Impact de l'IL-13 dans l'acquisition des fonctions tumoricides des macrophages : rôle des récepteurs lectine de type-C et implication dans la progression d'un lymphome T
Les macrophages associés aux tumeurs (TAMs) proviennent des monocytes circulants attirés par l'inflammation chronique due à la tumeur. Ces monocytes vont se différencier en une var...
Mucorales Species and Macrophages
Mucorales Species and Macrophages
Mucormycosis is an emerging fungal infection caused by Mucorales with an unacceptable high mortality rate. Mucorales is a complex fungal group, including eleven different genera th...
Rôle des facteurs de transcription NOR1 et TLE1 dans les macrophages alternatifs humains
Rôle des facteurs de transcription NOR1 et TLE1 dans les macrophages alternatifs humains
L’athérosclérose est une maladie inflammatoire chronique de la paroi vasculaire à évolution lente et silencieuse dont les principaux facteurs de risque sont les dyslipidémies, l’ob...
Nitric Oxide Protects Murine Embryonic Liver Cells (BNL CL.2) from Cytotoxicity Induced by Glucose Deprivation
Nitric Oxide Protects Murine Embryonic Liver Cells (BNL CL.2) from Cytotoxicity Induced by Glucose Deprivation
Abstract:We investigated the protective effects of nitric oxide on cell death of murine embryonic liver cells (BNL CL.2) after glucose deprivation. Endogenous nitric oxide producti...
Effect of endothelin-1 on endothelium-derived vascular responsiveness in man
Effect of endothelin-1 on endothelium-derived vascular responsiveness in man
1.Endothelium-dependent vasodilatation via nitric oxide in response to muscarinic stimulation is decreased in chronic heart failure while basal release of nitric oxide may be incre...
Nitric Oxide Pathways in Toxic Responses
Nitric Oxide Pathways in Toxic Responses
AbstractThe host response to chemically induced tissue injury is complex, involving a variety of cell types and soluble mediators. One of the most intensely investigated mediators ...
Role of Fractional Exhaled Nitric Oxide for Monitoring Bronchial Asthma
Role of Fractional Exhaled Nitric Oxide for Monitoring Bronchial Asthma
Background: Monitoring during treatment of asthma is usually done by various clinical tools, spirometry, sputum eosinophils and fractional exhaled nitric oxide. Fractional exhaled ...

